|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/46 | (2006.01) |
| (11) | Number of the document | 3161004 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15811659.0 |
| Date of filing the European patent application | 2015-06-19 | |
| (97) | Date of publication of the European application | 2017-05-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation | 2021-02-10 |
| (86) | Number | PCT/US2015/036634 |
| Date | 2015-06-19 |
| (87) | Number | WO 2015/200119 |
| Date | 2015-12-30 |
| (30) | Number | Date | Country code |
| 201462017467 P | 2014-06-26 | US |
| (72) |
BONVINI, Ezio, US
JOHNSON, Leslie S., US
SHAH, Kalpana, US
LA MOTTE-MOHS, Ross, US
MOORE, Paul A., US
KOENIG, Scott, US
|
| (73) |
MacroGenics, Inc.,
9704 Medical Center Drive, Rockville, MD 20850,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kovalentiškai sujungti diakūnai, pasižymintys imunoreaktyvumu PD-1 ir LAG-3 bei jų naudojimo būdai |
| COVALENTLY BONDED DIABODIES HAVING IMMUNOREACTIVITY WITH PD-1 AND LAG-3, AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-05-30 | 11 | 289.00 EUR |
| 2026-06-19 |